Zobrazeno 1 - 10
of 137
pro vyhledávání: '"John J Regan"'
Autor:
Paul C. McAfee, Fred H. Geisler, Richard D. Guyer, Louis G. Jenis, Richard T. Holt, Fabian D. Bitan, Stephen H. Hochschuler, Douglas Wong, John J. Regan, Andrew Cappuccino, Scott G. Tromanhauser, Mohamed E. Majd, Robert Banco, Scott L. Blumenthal
Publikováno v:
The Spine Journal. 9:374-386
Background context The CHARITE artificial disc, a lumbar spinal arthroplasty device, was approved by the United States Food and Drug Administration in 2004 based on two-year safety and effectiveness data from a multicenter, prospective, randomized in
Autor:
Todd J. Albert, John G. DeVine, John A. Hipp, Jeanette E. Ahrens, Andrew Cappuccino, Paul C. McAfee, Frank M. Phillips, Todd R. Allen, John J. Regan
Publikováno v:
Spine. 34:556-565
Study design Prospective 6-center study. OBJECTIVE.: To evaluate outcomes of cervical disc replacement performed adjacent to a prior cervical fusion. Summary of background data The use of disc replacement adjacent to a prior anterior cervical decompr
Autor:
John J. Regan, Pablo R. Pazmiño
Publikováno v:
Seminars in Spine Surgery. 20:34-45
Lumbar disc arthroplasty can be an effective treatment for the properly selected patient with recalcitrant pain from isolated degenerative disc disease when all conservative modalities have been exhausted. Artificial disc replacement represents an on
Autor:
Scott L. Blumenthal, Fred H. Geisler, Fabien D. Bitan, Paul C. McAfee, Richard D. Guyer, John J. Regan, Andrew Cappuccino
Publikováno v:
Journal of Neurosurgery: Spine. 8:13-16
Object Patient selection is perhaps the most important factor in successful lumbar surgery. In this study, the authors analyzed the clinical outcomes of patients enrolled in the CHARITÉ investigational device exemption (IDE) trial who underwent revi
Publikováno v:
Spine. 32:1001-1011
Study Design. A large case series of anterior revision surgery in patients who had complications following lumbar total disc replacement with the CHARITE artificial disc. Objectives. To analyze and discuss the etiology of implant-related complication
Autor:
John J. Regan, Rolando Garcia, Stephen H. Hochschuler, Jorge Isaza, Fred H. Geisler, Richard T. Holt, Paul C. McAfee, Richard D. Guyer, Scott L. Blumenthal, Mohammed Majd
Publikováno v:
SAS Journal
Background Previous reports of lumbar total disc replacement (TDR) have described significant complications. The US Food and Drug Administration (FDA) investigational device exemption (IDE) study of the Charite artificial disc represents the first le
Autor:
Willis H. Wagner, J. Patrick Johnson, Rajeev K. Rao, David V. Cossman, Todd H. Lanman, Scott P. Leary, John J. Regan
Publikováno v:
Journal of Vascular Surgery. 44:1266-1272
Background Several lumbar disc prostheses are being developed with the goal of preserving mobility in patients with degenerative disc disease. The disadvantage of lumbar artificial disc replacement (ADR) compared with anterior interbody fusion (ALIF)
Autor:
Richard D. Guyer, Paul C. McAfee, Fred H. Geisler, Scott L. Blumenthal, Rolando Garcia, James H. Maxwell, John J. Regan
Publikováno v:
Spine. 31:2270-2276
STUDY DESIGN A prospective, randomized, multicenter, Food and Drug Administration regulated Investigational Device Exemption (IDE) clinical trial. OBJECTIVES To discern whether there is a correlation between surgical volume and clinical outcomes, as
Autor:
Fred H. Geisler, Bryan W. Cunningham, P. Justin Tortolani, Sandra V. Moore, John J. Regan, Richard D. Guyer, Scott L. Blumenthal, Paul C. McAfee, Ira L. Fedder, Samer Saiedy
Publikováno v:
Spine. 31:1217-1226
Study design A prospective, randomized, multicenter, FDA-regulated Investigational Device Exemption clinical trial. Objectives To analyze the incidence of, and reasons for, reoperation in all patients (treatment and control) enrolled in the IDE study
Autor:
Paul C. McAfee, Donna D. Ohnmeiss, Rolando Garcia, Richard D. Guyer, Richard T. Holt, Scott L. Blumenthal, Stephen H. Hochschuler, John J. Regan, Fred H. Geisler
Publikováno v:
Spine. 30:1565-1575
STUDY DESIGN A prospective, randomized, multicenter, Food and Drug Administration-regulated Investigational Device Exemption clinical trial. OBJECTIVES The purpose of this study was to compare the safety and effectiveness of lumbar total disc replace